By Philips ∙ Featuring Prof. Junzhong Xu | March, 2024 | 2:47 min
Dr. Junzhong Xu, Director of Cancer Imaging Research at the Vanderbilt University Institute of Imaging Science discusses the development of MR cell size imaging [1] utilizing diffusion MRI. The imaging technique provides real-time data on cell size, density and membrane permeability and gradient strength is crucial for accurate measurements. The technology's ability to differentiate recurrent brain tumors from radiation injuries and track cell changes associated with chemotherapy-induced apoptosis is groundbreaking.
“Our ability to detect accurate mean cell size in tumors relies on the gradient strength we have. The stronger gradients we have, the more accurate and reliable measurements we can make. We will develop and validate a more advanced technology to evaluate tumors more comprehensively.”
Junzhong Xu, PhD
Director of Cancer Imaging Research
Vanderbilt University Institute of Imaging Science
Our periodic Radiology Insights newsletter provides you with the latest articles on user experiences and best practices.
[1] MR cell size imaging is being developed by the VUIIS and is not a product.
You are about to visit a Philips global content page
ContinueVeebilehel esitatud teave on mõeldud ainult isikutele, kes kasutavad meditsiiniseadmeid oma majandus- ja kutsetegevuses, sealhulgas tervishoiutöötajatele, tervishoiuteenuse osutajate esindajatele ning meditsiiniseadmetega oma majandus- ja kutsetegevuse raames kauplevatele isikutele. Veebilehel esitatud teave ei ole mõeldud meditsiiniliste nõuannete, ravijuhiste ega mistahes muude tervishoiualaste soovituste või suuniste andmiseks.
Kas olete isik, kes vastab ülaltoodud kriteeriumidele?